A newly published study reports that APC-deficient cancer cells may depend on a single metabolic enzyme for survival, ...
Targeted modulation of certain intracellular signaling proteins could represent an exciting new approach to drug development.
Olfactory receptors (ORs), the largest family within the G protein–coupled receptor (GPCR) superfamily, have long been recognized for their essential ...
Researchers report a drug discovery strategy using tailor-made cyclic peptides to target β-arrestins, key regulators of cellular signaling. This approach may enable precise control of disease-related ...
The World Federation of Societies of Biological Psychiatry (WFSBP) has reached consensus on candidate biomarkers for anorexia ...
The GPR133 receptor is expressed by osteoblasts, the cells that make bone. The study suggests that this receptor helps those cells sense two kinds of input: mechanical strain and signals relayed by ...
New Appointments Bring Deep Expertise in Immunology and Infectious Disease to Advance IND Submission and Intellectual Property StrategyJericho, ...
Gyre Therapeutics, Inc. (Gyre or Gyre Therapeutics) (Nasdaq: GYRE), a San Diego-based innovative commercial stage biopharmaceutical company with operations in the United States and China, today announ ...
Long COVID taste dysfunction linked to molecular changes in new study. Explore key findings and clinical impact. Read more.
In order to expel these functional variants from the cell, Professor Garbers and his team want to outsmart the ‘chaperones’ of ER quality control. In a first step, the researchers therefore want to ...
Full-year 2025 revenue increased 10% year-over-year to $116.6 million, within revised guidance rangeFull year 2026 revenue guidance of $100.5 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results